Condition Deep-Dives 10 min read·Updated 22 July 2026 Clinician-reviewed

Anti-GBM Disease (Goodpasture's)

A UK Consultant Nephrologist's guide to anti-GBM disease — a true nephrological emergency where every day of delay loses irreversible kidney function.

  • Clinically Reviewed
  • NHS & NICE Aligned
  • UK Evidence-Based
  • Last Reviewed 22 July 2026

Professor Mohammed Mahdi Althaf

Consultant Nephrologist & Acute Physician

View Credentials

Professor Mohammed Mahdi Althaf

MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN

Consultant Nephrologist & Acute Physician · GMC 7216325

View profile →

Direct answer

Anti-GBM disease causes rapidly progressive glomerulonephritis ± lung haemorrhage. Treat the same day with plasma exchange + steroids + cyclophosphamide. Earlier creatinine = better kidney outcome. Lungs usually recover fully.

Key recommendation: True nephrology emergency — treat within hours.

Quick answer

✓ Best choices

  • Plant proteins: beans, lentils, tofu, tempeh, chickpeas
  • Vegetables, fruit and whole grains
  • Oily fish 1–2 times a week
  • Olive oil as the main cooking fat

✓ Foods to limit

  • Added salt (≤ 6 g/day)
  • Processed meats and high-additive ready meals
  • Excess animal protein at every meal

Key takeaway

Anti-GBM disease causes rapidly progressive glomerulonephritis ± lung haemorrhage. Treat the same day with plasma exchange + steroids + cyclophosphamide. Earlier creatinine = better kidney outcome. Lungs usually recover fully.

Who should be cautious

People on dialysis, post-transplant, pregnant or breastfeeding, or taking prescription medication — confirm with your renal team before changes.

Anti-GBM Disease (Goodpasture's)

What is anti-GBM disease?

Anti-GBM disease is caused by autoantibodies (usually IgG) directed against the alpha-3 chain of collagen IV — the structural protein in the basement membranes of:

  • Kidney glomeruli (capillary filters)
  • Lung alveolar capillaries

The antibodies bind, trigger complement, and recruit neutrophils that destroy the basement membrane.

In Kidneys

  • Rapidly progressive glomerulonephritis with crescent formation
  • Can go from normal creatinine to dialysis within 1-2 weeks
  • Often the only manifestation in older adults

In Lungs

  • Alveolar haemorrhage — coughing blood, breathlessness, anaemia
  • Smokers and those exposed to hydrocarbons (paint thinners, fuels) have much higher lung disease
  • In non-smokers, lung disease is much less common

KIDNEY + LUNG = 'Goodpasture's syndrome' (historical eponym). Kidney only = anti-GBM disease.

Who Gets It

  • Very rare: ~1 per million per year in UK
  • Bimodal age peaks: 20-30 (often with lung involvement) and 60-70 (often kidney only)
  • Slight male predominance in young; equal in older
  • HLA-DR15 strongly associated
  • Often follows viral infection, influenza, or environmental trigger
  • Up to 30% are also ANCA positive ('double-positive') — important for prognosis

Symptoms and emergency diagnosis

Renal Symptoms

  • Visible blood in urine
  • Frothy urine (proteinuria)
  • Falling urine output
  • Ankle swelling
  • Fatigue, breathlessness (from anaemia or fluid)
  • Rising creatinine on routine blood test

Lung Symptoms

  • Cough
  • Breathlessness
  • Haemoptysis (coughing blood) — can be massive
  • Iron deficiency anaemia from chronic alveolar bleeding
  • Crackles on examination
  • Diffuse infiltrates on chest X-ray/CT

INVESTIGATIONS (URGENT — same day):

  • ANTI-GBM ANTIBODY blood test
  • ANCA (PR3, MPO)
  • Creatinine, eGFR (often rising rapidly)
  • Urine ACR, microscopy (red cells, red cell casts)
  • FBC (anaemia)
  • Coagulation
  • Chest X-ray ± CT
  • Bronchoscopy if pulmonary haemorrhage suspected

Kidney Biopsy

  • Crescentic glomerulonephritis (often 80-100% of glomeruli have crescents)
  • Linear IgG deposition along glomerular basement membrane on immunofluorescence (pathognomonic)
  • Should be performed urgently — do NOT delay treatment waiting for biopsy

TREATMENT STARTS ON SUSPICION — confirmed anti-GBM antibody + crescentic GN clinical picture is enough.

Kidney Vitality is a daily multivitamin developed by a UK Consultant Nephrologist using renal nutrition principles. It contains no added potassium, magnesium, phosphorus or iron, and no herbal blends. See the formulation.

Treatment — combined and urgent

STANDARD REGIME — all three started together:

1. Plasma Exchange (Plex)

  • Daily for 14 days or until anti-GBM antibody undetectable
  • Removes circulating antibody
  • 4L per session, fresh frozen plasma or albumin replacement
  • Needs central line

2. Corticosteroids

  • IV methylprednisolone 500-1000 mg ×3 days
  • Then oral prednisolone 1 mg/kg/day
  • Slow taper over 6 months

3. Cyclophosphamide

  • Oral 2 mg/kg/day (max 200 mg)
  • Continue for 3 months total
  • Then stop — disease rarely relapses
  • Bone marrow monitoring (weekly FBC)
  • Reduce dose if eGFR < 30 or age > 60

Adjuncts

  • Co-trimoxazole 480 mg daily (PCP pneumonia prophylaxis)
  • Bone protection (calcium, vitamin D, bisphosphonate)
  • PPI gastric protection
  • Antifungal prophylaxis with high-dose steroids
  • MESNA with cyclophosphamide (bladder protection)
  • Antiemetics
  • Stop smoking IMMEDIATELY — smoking dramatically worsens lung disease
  • Avoid hydrocarbon exposure

Newer

  • Rituximab considered in some cases (especially if cyclophosphamide contraindicated)
  • Imlifidase (IdeS) — cleaves circulating IgG; under study
  • Emergency haemodialysis if needed (does not preclude treatment)

Prognosis and what to expect

KIDNEY OUTCOMES depend on presentation:

GOOD prognosis if:

  • Creatinine < 500 µmol/L at start
  • Not yet dialysis-dependent
  • Few crescents on biopsy (< 50%)
  • No oliguria

→ 80-90% kidney recovery

POOR prognosis if:

  • Creatinine > 500 at start
  • Dialysis-dependent at presentation
  • > 85% crescents on biopsy
  • Oliguria/anuria

→ < 10% recover off dialysis

In the latter group, current guidance suggests NOT starting heavy immunosuppression unless lung haemorrhage is also present (no kidney benefit, high infection risk). Always individualised.

Lung Outcomes

  • Usually fully recover with treatment
  • Lifelong small reduction in lung function tests
  • Stop smoking is non-negotiable

Relapse

  • Very rare unlike ANCA vasculitis (< 3%)
  • Lifelong follow-up still recommended
  • Annual anti-GBM, urine, creatinine, BP

Transplant

  • Wait 6-12 months after anti-GBM becomes negative
  • Living donor or deceased donor
  • Rarely recurs in graft
  • Outcomes excellent — equivalent to other causes

Living with anti-GBM disease

EARLY POST-TREATMENT (months 0-6):

  • Frequent clinic visits — weekly to monthly
  • Watch for infection on immunosuppression
  • Recovery often slow; emotional support important
  • Physiotherapy and rehabilitation
  • Patient organisations: Kidney Care UK

LATER (year 1 onwards):

  • 3-6 monthly nephrology review
  • Annual anti-GBM antibody
  • BP, urine ACR, creatinine
  • Lifelong avoidance of smoking, hydrocarbon exposure
  • Cardiovascular risk factor optimisation
  • Address mental health — this is a traumatic illness

If Dialysis-dependent

  • Decisions about transplant
  • Modality choice (HD vs PD)
  • Holiday dialysis planning
  • Diet and lifestyle adjustments
  • See our Preparing for Dialysis and Dialysis Diet guides

Family

  • Not inherited (sporadic)
  • Family screening not needed

If You Smoke Or Work With Solvents

  • Smoking quintuples lung disease risk in anti-GBM
  • Hairdressers, painters, mechanics, petrol station workers — discuss occupational exposure with team
  • Even cured patients should avoid these triggers lifelong
ANCA-Associated Vasculitis
Related reading: ANCA-Associated Vasculitis.

Key practical tips

Designed for quick scanning — what to order, what to avoid, sensible portions, common mistakes.

  • Take prescribed ACE inhibitor / ARB / SGLT2 inhibitor consistently — diet works alongside, not instead
  • Monitor BP at home weekly
  • Review urine ACR with your team to track progress

Clinical guidance

TL;DR summary

Anti-GBM disease causes rapidly progressive glomerulonephritis ± lung haemorrhage. Treat the same day with plasma exchange + steroids + cyclophosphamide. Earlier creatinine = better kidney outcome. Lungs usually recover fully.

Key takeaways
  • True nephrology emergency — treat within hours.
  • Plasma exchange + steroids + cyclophosphamide = standard.
  • Creatinine < 500 = good kidney recovery; > 500 = poor.
  • Lung haemorrhage can be life-threatening — A&E.
  • Smokers and inhaled hydrocarbon exposure have higher lung disease.
Kidney Diet & Nutrition Considerations

When protein is leaking into the urine, the goal is to protect the remaining kidney function. Dietary protein should be sensible — neither very high nor unnecessarily low — and a Mediterranean-style plate with reduced salt supports both blood pressure and albuminuria reduction alongside ACE inhibitors, ARBs or SGLT2 inhibitors.

Foods to prioritise

  • Plant proteins: beans, lentils, tofu, tempeh, chickpeas
  • Vegetables, fruit and whole grains
  • Oily fish 1–2 times a week
  • Olive oil as the main cooking fat

Foods to limit

  • Added salt (≤ 6 g/day)
  • Processed meats and high-additive ready meals
  • Excess animal protein at every meal

Potassium, phosphate and protein needs vary between individuals — please confirm personal targets with your renal team or dietitian. Browse the Kidney Diet Hub for more guides in this cluster.

Frequently asked questions

What is anti-GBM disease?

Anti-glomerular basement membrane (anti-GBM) disease — historically Goodpasture's syndrome — is a rare autoimmune disease where antibodies attack collagen IV in the kidneys and lungs. It causes rapidly progressive glomerulonephritis ± pulmonary haemorrhage, and without urgent treatment leads to kidney failure within days to weeks.

What symptoms should I watch for?

Cough, breathlessness, coughing blood (haemoptysis), unexplained anaemia, weight loss, fatigue, blood in urine, falling urine output, swollen ankles. Anyone with this combination — especially with rising creatinine — needs urgent renal assessment the same day.

What's the treatment?

Three combined treatments started together: plasma exchange (daily for 14 days), high-dose IV methylprednisolone then oral steroids, and oral cyclophosphamide for 3 months. Lifelong follow-up. Earlier rituximab is being studied for some cases.

Will I need dialysis?

If creatinine is < 500 µmol/L and there are no crescents on biopsy, the chance of kidney recovery is good. If creatinine > 500 or you are already on dialysis at presentation, kidney recovery is unfortunately rare and most patients remain dialysis-dependent. Lungs usually recover fully with treatment.

Can diet reduce protein in urine?

A reduced-salt, Mediterranean-style diet with sensible protein intake can lower urine protein, particularly when combined with prescribed ACE inhibitors, ARBs or SGLT2 inhibitors. Very low-protein diets are not routinely recommended without dietitian supervision.

Nutritional challenges in kidney disease

Many people living with kidney disease have to limit foods because of potassium, phosphate, diabetes, dialysis, appetite changes or simply the time it takes to cook from scratch every day. That can make it harder to keep daily nutrition balanced — particularly for vitamins and minerals that food alone may not fully cover.

Kidney Vitality is a UK-formulated daily nutritional support product designed by Consultant Nephrologist Professor Mohammed Mahdi Althaf with renal nutrition in mind from the start. It keeps doses moderate, leaves out added potassium, phosphate and magnesium, and avoids megadose vitamin A — sitting alongside a kidney-friendly diet, not replacing it.

Why Kidney Vitality fits this need

Built around UK renal guidance

Aligned with KDIGO 2024 ANCA-Associated Vasculitis and Anti-GBM, and UK Renal Association rapidly progressive GN guidance.

Designed by a UK Consultant Nephrologist

Formulated and reviewed by Professor Mohammed Mahdi Althaf (GMC 7216325).

Evidence-based by design

Practical UK guidance for adults affected by anti-GBM disease.

Designed by a UK Consultant Nephrologist

Ready to support your kidney health?

If you have been researching kidney health, supplements, CKD nutrition or kidney-friendly living, Kidney Vitality was developed specifically around those principles by Professor Mohammed Mahdi Althaf (GMC 7216325). Nephrologist Developed Daily Multivitamin.

  • No Added Potassium
  • No Added Magnesium
  • No Added Phosphorus
  • No Added Iron
  • One capsule daily
  • UK GMP — BRCGS, NSF GMP, Halal

✓ Free UK tracked delivery  ·  ✓ Delivered every 30 days  ·  ✓ Pause or cancel anytime  ·  ✓ Never run out

ComparisonKidney VitalityTypical high-street multivitamin
Added potassiumNoneOften included
Added phosphateNoneOften included (E338–E452)
Vitamin A (retinol)No megadoseOften high-dose retinol
Kidney-focused formulationYesNo — general population
Consultant Nephrologist involvementYes (GMC 7216325)No
UK GMP manufacturedYes (BRCGS, NSF GMP)Varies

Food supplement. Not a medicine and not a treatment for kidney disease. Speak with your GP, pharmacist or renal team before starting any new supplement, especially in advanced CKD, on dialysis, post-transplant, pregnant or breastfeeding.

Clinical reviewer

Professor Mohammed Mahdi Althaf

Consultant Nephrologist

Acute Physician

GMC 7216325

View Full Biography

Professor Mohammed Mahdi Althaf is a UK Consultant Nephrologist and Acute Physician with a special interest in chronic kidney disease, AKI prevention and renal nutrition. He combines hospital practice with patient education and clinical guidance review.

View professional profile →
View Credentials
  • MD
  • MSc
  • PgDip (Clin Ed)
  • FRCP
  • FHEA
  • FASN

About this article

Written for UK patients and based on:

  • NICE guidance
  • NHS resources
  • British Dietetic Association guidance
  • Kidney Care UK resources
View methodology

Each article is researched against current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO and KDOQI international guidelines, and the British Dietetic Association Renal Nutrition Group. Drafts are written by the Kidney Vitality editorial team and reviewed by a UK Consultant Nephrologist before publication. Content is reviewed on a rolling basis and updated when guidance changes.

Editorial standards

  • Clinically reviewed
  • NHS-aligned
  • NICE-aligned
  • Evidence-based
  • Reviewed before publication
View full editorial process

Every article is researched and written by the Kidney Vitality editorial team using current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO/KDOQI international guidelines, and British Dietetic Association renal nutrition guidance. Drafts are reviewed for clinical accuracy by Professor Mohammed Mahdi Althaf, MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN (Consultant Nephrologist & Acute Physician, GMC 7216325) before publication. Content is updated when UK guidance changes.

References (4)View Sources
  1. NICE NG203: Chronic kidney disease — assessment and management
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
  3. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
  4. British Dietetic Association — Renal Nutrition Group

Medical disclaimer

This content is educational only and does not replace personalised medical advice.

Read full disclaimer

This page is general information, not personal medical advice. If you have chronic kidney disease, are on dialysis, have had a kidney transplant, are pregnant or breastfeeding, or take prescription medication, please confirm any supplement with your GP, pharmacist or renal team before starting.